IBEX Announces Record First Quarter of Fiscal Year 2025 Financial Results
IBEX reported record first quarter fiscal 2025 results with revenue increasing 4.1% to $129.7 million. Net income grew 1.4% to $7.5 million, while adjusted EBITDA rose 13.7% to $15.6 million with margin expansion to 12.0%. Growth was driven by strong performance in HealthTech (+23.4%), Retail & E-commerce (+8.6%), and Travel sectors (+10.0%), partially offset by FinTech decline (-13.0%). The company repurchased approximately 282,000 shares for $4.7 million and updated FY2025 revenue guidance to $515-525 million with adjusted EBITDA of $67-69 million.
IBEX ha riportato risultati record per il primo trimestre dell'esercizio fiscale 2025, con un aumento del fatturato del 4,1% a 129,7 milioni di dollari. L'utile netto è cresciuto dell'1,4% a 7,5 milioni di dollari, mentre l'EBITDA rettificato è aumentato del 13,7% a 15,6 milioni di dollari, con un'espansione del margine al 12,0%. La crescita è stata trainata da forti performance nei settori HealthTech (+23,4%), Retail & E-commerce (+8,6%) e Viaggi (+10,0%), parzialmente compensate dal calo del settore FinTech (-13,0%). L'azienda ha riacquistato circa 282.000 azioni per 4,7 milioni di dollari e ha aggiornato le previsioni di fatturato per l'anno fiscale 2025 a 515-525 milioni di dollari, con un EBITDA rettificato di 67-69 milioni di dollari.
IBEX reportó resultados récord para el primer trimestre del año fiscal 2025, con un aumento del 4,1% en los ingresos a 129,7 millones de dólares. Las ganancias netas crecieron un 1,4% alcanzando los 7,5 millones de dólares, mientras que el EBITDA ajustado se incrementó un 13,7% a 15,6 millones de dólares, con una expansión del margen al 12,0%. El crecimiento fue impulsado por un sólido desempeño en los sectores de HealthTech (+23,4%), Retail y E-commerce (+8,6%) y Viajes (+10,0%), compensado parcialmente por la caída en FinTech (-13,0%). La compañía recompró aproximadamente 282,000 acciones por 4,7 millones de dólares y actualizó la guía de ingresos para el año fiscal 2025 a 515-525 millones de dólares con un EBITDA ajustado de 67-69 millones de dólares.
IBEX는 2025 회계년도 첫 분기 실적이 기록적이었다고 보고하며, 수익이 4.1% 증가하여 1억 2,970만 달러에 이르렀습니다. 순이익은 1.4% 증가하여 750만 달러가 되었고, 조정된 EBITDA는 13.7% 증가하여 1,560만 달러에 도달하며 마진이 12.0%로 확대되었습니다. 성장은 HealthTech (+23.4%), 소매 및 전자상거래 (+8.6%), 여행 부문 (+10.0%)의 강력한 실적에 의해 주도되었으며, 부분적으로 FinTech 부문의 감소 (-13.0%)로 상쇄되었습니다. 회사는 약 282,000주를 470만 달러에 재구매했으며, 2025 회계년도 수익 가이드를 5억 1,500-5억 2,500만 달러로 업데이트하고 조정된 EBITDA는 6,700-6,900만 달러로 제시했습니다.
IBEX a annoncé des résultats record pour le premier trimestre de l'exercice 2025, avec un chiffre d'affaires en hausse de 4,1% à 129,7 millions de dollars. Le revenu net a augmenté de 1,4% pour atteindre 7,5 millions de dollars, tandis que l'EBITDA ajusté a crû de 13,7% pour atteindre 15,6 millions de dollars, avec une expansion de la marge à 12,0%. La croissance a été soutenue par de solides performances dans les secteurs HealthTech (+23,4%), Retail et E-commerce (+8,6%) et Voyages (+10,0%), partiellement compensées par une baisse dans le secteur FinTech (-13,0%). L'entreprise a racheté environ 282 000 actions pour 4,7 millions de dollars et a mis à jour ses prévisions de chiffre d'affaires pour l'exercice 2025 à 515-525 millions de dollars, avec un EBITDA ajusté de 67-69 millions de dollars.
IBEX berichtete von rekordverdächtigen Ergebnissen im ersten Quartal des Geschäftsjahres 2025, mit einem Anstieg des Umsatzes um 4,1% auf 129,7 Millionen Dollar. Der Nettogewinn stieg um 1,4% auf 7,5 Millionen Dollar, während das bereinigte EBITDA um 13,7% auf 15,6 Millionen Dollar anstieg, wobei die Marge auf 12,0% erweitert wurde. Das Wachstum wurde durch starke Leistungen in den Bereichen HealthTech (+23,4%), Einzelhandel und E-Commerce (+8,6%) sowie Reisen (+10,0%) vorangetrieben, teilweise ausgeglichen durch einen Rückgang im FinTech-Bereich (-13,0%). Das Unternehmen hat etwa 282.000 Aktien für 4,7 Millionen Dollar zurückgekauft und die Umsatzprognose für das Geschäftsjahr 2025 auf 515-525 Millionen Dollar mit einem bereinigten EBITDA von 67-69 Millionen Dollar aktualisiert.
- Revenue grew 4.1% YoY to $129.7 million
- Adjusted EBITDA increased 13.7% to $15.6 million with margin expansion to 12.0%
- Adjusted EPS grew 28.9% to $0.52
- HealthTech vertical grew 23.4%
- Strong cash position with $60.8 million net cash
- Net income margin decreased to 5.8% from 6.0%
- FinTech vertical declined 13.0%
- Free cash flow decreased to $4.1 million from $6.6 million YoY
- Capital expenditures increased to $3.6 million from $2.1 million
Insights
The Q1 FY25 results demonstrate robust financial performance with notable achievements. Revenue grew
- Strong sector performance in HealthTech (
+23.4% ) and Retail & E-commerce (+8.6% ) - Impressive margin expansion with adjusted EBITDA margin reaching
12% - Significant EPS growth with adjusted EPS up
28.9% to$0.52
The company's strategic share repurchase program, acquiring 282,000 shares at
IBEX's strategic pivot towards AI integration and customer-facing automation solutions marks a significant technological advancement. The company's success in securing two key wins in automation and translation AI demonstrates market validation of their tech-forward approach. The increased capital expenditure of
- Record first quarter revenue, net income, EPS, and adjusted EBITDA
- Strong adjusted EBITDA margin expansion year-over-year - nine out of the last ten quarters
- Repurchased approximately 282,000 shares at a total cost of
$4.7 million during first quarter of fiscal year 2025, representing1.7% of our shares outstanding at September 30, 2024
WASHINGTON, Nov. 07, 2024 (GLOBE NEWSWIRE) -- IBEX Limited (“ibex”), a leading provider in global business process outsourcing and end-to-end customer engagement technology solutions, today announced financial results for its first fiscal quarter ended September 30, 2024.
| Three months ended September 30, | |||||||||||
| ($ millions, except per share amounts) | 2024 | 2023 | Change | ||||||||
| Revenue | $ | 129.7 | $ | 124.6 | 4.1 | % | |||||
| Net income | $ | 7.5 | $ | 7.4 | 1.4 | % | |||||
| Net income margin | 5.8 | % | 6.0 | % | (20 | ) bps | |||||
| Adjusted net income (1) | $ | 9.0 | $ | 7.6 | 19.3 | % | |||||
| Adjusted net income margin (1) | 7.0 | % | 6.1 | % | 90 | bps | |||||
| Adjusted EBITDA (1) | $ | 15.6 | $ | 13.7 | 13.7 | % | |||||
| Adjusted EBITDA margin (1) | 12.0 | % | 11.0 | % | 100 | bps | |||||
| Earnings per share - diluted | $ | 0.43 | $ | 0.39 | 9.6 | % | |||||
| Adjusted earnings per share - diluted (1) | $ | 0.52 | $ | 0.40 | 28.9 | % | |||||
| (1)See accompanying Exhibits for the reconciliation of each non-GAAP measure to its most directly comparable GAAP measure. | |||||||||||
“Coming off a very strong second half of fiscal year 2024, I am delighted to report that fiscal year 2025 is off to a banner start with record first quarter results across the majority of our key financial metrics,” said Bob Dechant, ibex CEO. “Q1 saw a return to growth for ibex with revenues growing over
“Q1 FY25 was also a strong quarter on all profitability metrics where adjusted EPS grew
First Quarter Financial Performance
Revenue
- Revenue of
$129.7 million , an increase of4.1% from$124.6 million in the prior year quarter. Growth in HealthTech (+23.4% ), Retail & E-commerce (+8.6% ), and Travel, Transportation and Logistics (+10.0% ), was partially offset by declines in the FinTech vertical (-13.0% ).
Net Income and Earnings Per Share
- Net income increased to
$7.5 million compared to$7.4 million in the prior year quarter. Diluted earnings per share increased to$0.43 compared to$0.39 in the prior year quarter. The increases were primarily the result of the impact of higher revenue, improved gross margin performance on the year over year growth of delivery in our offshore regions, cost optimization efforts, and fewer diluted shares outstanding compared to the prior year quarter. - Net income margin decreased to
5.8% compared to6.0% in the prior year quarter. - Non-GAAP adjusted net income increased to
$9.0 million compared to$7.6 million in the prior year quarter (see Exhibit 1 for reconciliation). - Non-GAAP adjusted diluted earnings per share increased to
$0.52 compared to$0.40 in the prior year quarter (see Exhibit 1 for reconciliation). The increase per share was primarily attributable to the impact of higher revenue, improved operating margins and a lower share count.
Non-GAAP adjusted EBITDA
- Adjusted EBITDA increased to
$15.6 million compared to$13.7 million in the prior year quarter (see Exhibit 2 for reconciliation). - Adjusted EBITDA margin increased to
12.0% compared to11.0% in the prior year quarter (see Exhibit 2 for reconciliation).
Cash Flow and Balance Sheet
- Repurchased approximately 282,000 shares during the quarter at a total cost of
$4.7 million , and an average price per share of$16.55 , representing1.7% of our shares outstanding at September 30, 2024. - Capital expenditures were
$3.6 million compared to$2.1 million in the prior year quarter. The increase in capital expenditures during the current year quarter was driven by expansion to meet growing demand in our offshore and nearshore geographies. - Free cash flow was
$4.1 million compared to$6.6 million in the prior year quarter (see Exhibit 3 for reconciliation). - Net cash was
$60.8 million , slightly down from$61.2 million as of June 30, 2024 (see Exhibit 4 for reconciliation).
First Quarter Fiscal 2025 Business Outlook
“We further built our top-line momentum in the first quarter with
Fiscal Year 2025 Guidance
- For fiscal year 2025, revenue is expected to be in the range of
$515 t o$525 million , raising the lower end of the previous range from$510 million . - Adjusted EBITDA is expected to be in the range of
$67 t o$69 million . - Capital expenditures for fiscal year 2025 are expected to be in the range of
$15 t o$20 million .
Conference Call and Webcast Information
IBEX Limited will host a conference call and live webcast to discuss its first quarter of fiscal year 2025 financial results at 4:30 p.m. Eastern Time today, November 7, 2024. We will also post to this section of our website the earning slides, which will accompany our conference call and live webcast, and encourage you to review the information that we make available on our website.
Live and archived webcasts can be accessed at: https://investors.ibex.co/.
Financial Information
This announcement does not contain sufficient information to constitute an interim financial report as defined in Financial Accounting Standards ASC 270, “Interim Reporting.” The financial information in this press release has not been audited.
Non-GAAP Financial Measures
We present non-GAAP financial measures because we believe that they and other similar measures are widely used by certain investors, securities analysts and other interested parties as supplemental measures of performance and liquidity. We also use these measures internally to establish forecasts, budgets and operational goals to manage and monitor our business, as well as evaluate our underlying historical performance, as we believe that these non-GAAP financial measures provide a more helpful depiction of our performance of the business by encompassing only relevant and manageable events, enabling us to evaluate and plan more effectively for the future. The non-GAAP financial measures may not be comparable to other similarly titled measures of other companies, have limitations as analytical tools, and should not be considered in isolation or as a substitute for analysis of our operating results as reported in accordance with accounting principles generally accepted in the United States (“GAAP”). Non-GAAP financial measures and ratios are not measurements of our performance, financial condition or liquidity under GAAP and should not be considered as alternatives to operating profit or net income / (loss) or as alternatives to cash flow from operating, investing or financing activities for the period, or any other performance measures, derived in accordance with GAAP.
ibex is not providing a quantitative reconciliation of forward-looking non-GAAP adjusted EBITDA margin to the most directly comparable GAAP measure because it is unable to predict with reasonable certainty the ultimate outcome of certain significant items without unreasonable effort. These items include, but are not limited to, non-recurring expenses, foreign currency gains and losses, and share-based compensation expense. These items are uncertain, depend on various factors, and could have a material impact on GAAP reported results for the guidance period.
About ibex
ibex helps the world’s preeminent brands more effectively engage their customers with services ranging from customer support, technical support, inbound/outbound sales, business intelligence and analytics, digital demand generation, and CX surveys and feedback analytics.
Forward Looking Statements
In addition to historical information, this press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “predict,” “potential,” or the negative of these terms or other similar expressions. These statements include, but are not limited to, statements regarding our future financial and operating performance, including our outlook and guidance, and our strategies, priorities and business plans. Our expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Factors that could impact our actual results include: our ability to attract new business and retain key clients; our profitability based on our utilization, pricing and managing costs; the potential for our clients or potential clients to consolidate; our clients deciding to enter into or further expand their insourcing activities and current trends toward outsourcing services may reverse; general economic uncertainty in global markets and unfavorable economic conditions, including inflation, rising interest rates, recession, foreign exchange fluctuations and supply-chain issues; our ability to manage our international operations, particularly in the Philippines, Jamaica, Pakistan and Nicaragua; natural events, health epidemics, global geopolitical conditions, including developing or ongoing conflicts, widespread civil unrest, terrorist attacks and other attacks of violence involving any of the countries in which we or our clients operate; our ability to anticipate, develop and implement information technology solutions that keep pace with evolving industry standards and changing client demands, including the effective adoption of Artificial Intelligence into our offerings; our ability to recruit, engage, motivate, manage and retain our global workforce; our ability to comply with applicable laws and regulations, including those regarding privacy, data protection and information security, employment and anti-corruption; the effect of cyberattacks or cybersecurity vulnerabilities on our information technology systems; our ability to realize the anticipated strategic and financial benefits of our relationship with Amazon; the impact of tax matters, including new legislation and actions by taxing authorities; and other factors discussed in the “Risk Factors” described in our periodic reports filed with the U.S. Securities and Exchange Commission (“SEC”), including our annual reports on Form 10-K, quarterly reports on Form 10-Q, and past filings on Form 20-F, and any other risk factors we include in subsequent filings with the SEC. Because of these uncertainties, you should not make any investment decisions based on our estimates and forward-looking statements. Except as required by law, we undertake no obligation to publicly update any forward-looking statements for any reason after the date of this press release whether as a result of new information, future events or otherwise.
IR Contact: Michael Darwal, EVP, Investor Relations, ibex, michael.darwal@ibex.co
Media Contact: Daniel Burris, Senior Director PR and Communication, ibex, daniel.burris@ibex.co
| IBEX LIMITED AND SUBSIDIARIES Consolidated Balance Sheets (Unaudited) (in thousands) | ||||||||
| September 30, 2024 | June 30, 2024 | |||||||
| Assets | ||||||||
| Current assets | ||||||||
| Cash and cash equivalents | $ | 62,305 | $ | 62,720 | ||||
| Accounts receivable, net | 106,043 | 98,366 | ||||||
| Prepaid expenses | 8,202 | 7,712 | ||||||
| Due from related parties | 256 | 192 | ||||||
| Tax advances and receivables | 10,153 | 9,080 | ||||||
| Other current assets | 1,571 | 1,888 | ||||||
| Total current assets | 188,530 | 179,958 | ||||||
| Non-current assets | ||||||||
| Property and equipment, net | 33,202 | 29,862 | ||||||
| Operating lease assets | 58,806 | 59,145 | ||||||
| Goodwill | 11,832 | 11,832 | ||||||
| Deferred tax asset, net | 4,414 | 4,285 | ||||||
| Other non-current assets | 9,491 | 8,822 | ||||||
| Total non-current assets | 117,745 | 113,946 | ||||||
| Total assets | $ | 306,275 | $ | 293,904 | ||||
| Liabilities and stockholders' equity | ||||||||
| Current liabilities | ||||||||
| Accounts payable and accrued liabilities | $ | 19,797 | $ | 16,719 | ||||
| Accrued payroll and employee-related liabilities | 34,095 | 30,674 | ||||||
| Current deferred revenue | 4,873 | 4,749 | ||||||
| Current operating lease liabilities | 12,395 | 12,051 | ||||||
| Current maturities of long-term debt | 698 | 660 | ||||||
| Due to related parties | 25 | 60 | ||||||
| Income taxes payable | 5,889 | 6,083 | ||||||
| Total current liabilities | 77,772 | 70,996 | ||||||
| Non-current liabilities | ||||||||
| Non-current deferred revenue | 1,083 | 1,128 | ||||||
| Non-current operating lease liabilities | 52,832 | 53,441 | ||||||
| Long-term debt | 802 | 867 | ||||||
| Other non-current liabilities | 2,695 | 1,673 | ||||||
| Total non-current liabilities | 57,412 | 57,109 | ||||||
| Total liabilities | 135,184 | 128,105 | ||||||
| Stockholders' equity | ||||||||
| Common stock | 2 | 2 | ||||||
| Additional paid-in capital | 210,872 | 210,200 | ||||||
| Treasury stock | (30,045 | ) | (25,367 | ) | ||||
| Accumulated other comprehensive loss | (6,146 | ) | (7,913 | ) | ||||
| Accumulated deficit | (3,592 | ) | (11,123 | ) | ||||
| Total stockholders' equity | 171,091 | 165,799 | ||||||
| Total liabilities and stockholders' equity | $ | 306,275 | $ | 293,904 | ||||
| IBEX LIMITED AND SUBSIDIARIES Consolidated Statements of Comprehensive Income (Unaudited) (in thousands, except per share data) | ||||||||
| Three Months Ended September 30, | ||||||||
| 2024 | 2023 | |||||||
| Revenue | $ | 129,717 | $ | 124,609 | ||||
| Cost of services (exclusive of depreciation and amortization presented separately below) | 90,041 | 88,196 | ||||||
| Selling, general and administrative | 26,215 | 23,040 | ||||||
| Depreciation and amortization | 4,369 | 5,042 | ||||||
| Total operating expenses | 120,625 | 116,278 | ||||||
| Income from operations | 9,092 | 8,331 | ||||||
| Interest income | 583 | 586 | ||||||
| Interest expense | (162 | ) | (104 | ) | ||||
| Income before income taxes | 9,513 | 8,813 | ||||||
| Provision for income tax expense | (1,982 | ) | (1,388 | ) | ||||
| Net income | $ | 7,531 | $ | 7,425 | ||||
| Other comprehensive income | ||||||||
| Foreign currency translation adjustments | $ | 1,388 | $ | (701 | ) | |||
| Unrealized gain / (loss) on cash flow hedging instruments, net of tax | 379 | (194 | ) | |||||
| Total other comprehensive income / (loss) | 1,767 | (895 | ) | |||||
| Total comprehensive income | $ | 9,298 | $ | 6,530 | ||||
| Net income per share | ||||||||
| Basic | $ | 0.45 | $ | 0.41 | ||||
| Diluted | $ | 0.43 | $ | 0.39 | ||||
| Weighted average common shares outstanding | ||||||||
| Basic | 16,880 | 18,287 | ||||||
| Diluted | 17,490 | 18,898 | ||||||
| IBEX LIMITED AND SUBSIDIARIES Consolidated Statements of Cash Flows (Unaudited) (in thousands) | ||||||||
| Three Months Ended September 30, | ||||||||
| 2024 | 2023 | |||||||
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net income | $ | 7,531 | $ | 7,425 | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
| Depreciation and amortization | 4,369 | 5,042 | ||||||
| Noncash lease expense | 3,326 | 3,225 | ||||||
| Warrant contra revenue | — | 287 | ||||||
| Deferred income tax | (130 | ) | 244 | |||||
| Share-based compensation expense | 670 | 848 | ||||||
| Allowance of expected credit losses | 83 | 11 | ||||||
| Change in assets and liabilities: | ||||||||
| Increase in accounts receivable | (7,649 | ) | (3,792 | ) | ||||
| Increase in prepaid expenses and other current assets | (1,735 | ) | (1,256 | ) | ||||
| Increase in accounts payable and accrued liabilities | 4,574 | 206 | ||||||
| Increase / (decrease) in deferred revenue | 79 | (372 | ) | |||||
| Decrease in operating lease liabilities | (3,356 | ) | (3,184 | ) | ||||
| Net cash inflow from operating activities | 7,762 | 8,684 | ||||||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Purchase of property and equipment | (3,630 | ) | (2,052 | ) | ||||
| Net cash outflow from investing activities | (3,630 | ) | (2,052 | ) | ||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Proceeds from line of credit | 60 | 37 | ||||||
| Repayments of line of credit | (60 | ) | (89 | ) | ||||
| Proceeds from the exercise of options | 382 | 5 | ||||||
| Principal payments on finance leases | (171 | ) | (88 | ) | ||||
| Purchase of treasury shares | (4,807 | ) | (1,832 | ) | ||||
| Net cash outflow from financing activities | (4,596 | ) | (1,967 | ) | ||||
| Effects of exchange rate difference on cash and cash equivalents | 49 | (65 | ) | |||||
| Net (decrease) / increase in cash and cash equivalents | (415 | ) | 4,600 | |||||
| Cash and cash equivalents, beginning | 62,720 | 57,429 | ||||||
| Cash and cash equivalents, ending | $ | 62,305 | $ | 62,029 | ||||
| IBEX LIMITED AND SUBSIDIARIES Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures | |
EXHIBIT 1: Adjusted net income, adjusted net income margin, and adjusted earnings per share
We define adjusted net income as net income before the effect of the following items: warrant contra revenue, foreign currency gain / loss, and share-based compensation expense, net of the tax impact of such adjustments. We define adjusted net income margin as adjusted net income divided by revenue. We define adjusted earnings per share as adjusted net income divided by weighted average diluted shares outstanding.
The following table provides a reconciliation of net income to adjusted net income, net income margin to adjusted net income margin, and diluted earnings per share to adjusted earnings per share for the periods presented:
| Three Months Ended September 30, | ||||||||
| ( | 2024 | 2023 | ||||||
| Net income | $ | 7,531 | $ | 7,425 | ||||
| Net income margin | 5.8 | % | 6.0 | % | ||||
| Warrant contra revenue | — | 287 | ||||||
| Foreign currency loss / (gain) | 1,457 | (797 | ) | |||||
| Share-based compensation expense | 670 | 848 | ||||||
| Total adjustments | $ | 2,127 | $ | 338 | ||||
| Tax impact of adjustments1 | (626 | ) | (189 | ) | ||||
| Adjusted net income | $ | 9,032 | $ | 7,574 | ||||
| Adjusted net income margin | 7.0 | % | 6.1 | % | ||||
| Diluted earnings per share | $ | 0.43 | $ | 0.39 | ||||
| Per share impact of adjustments to net income | 0.09 | 0.01 | ||||||
| Adjusted earnings per share | $ | 0.52 | $ | 0.40 | ||||
| Weighted average diluted shares outstanding | 17,490 | 18,898 | ||||||
| (1)The tax impact of each adjustment is calculated using the effective tax rate in the relevant jurisdictions. | ||||||||
EXHIBIT 2: EBITDA, adjusted EBITDA, and adjusted EBITDA margin
EBITDA is a non-GAAP profitability measure that represents net income before the effect of the following items: interest expense, income tax expense, and depreciation and amortization. Adjusted EBITDA is a non-GAAP profitability measure that represents EBITDA before the effect of the following items: interest income, warrant contra revenue, foreign currency gain / loss, and share-based compensation expense. Adjusted EBITDA margin is a non-GAAP profitability measure that represents adjusted EBITDA divided by revenue.
The following table provides a reconciliation of net income to EBITDA and adjusted EBITDA and net income margin to adjusted EBITDA margin for the periods presented:
| Three Months Ended September 30, | ||||||||
| ( | 2024 | 2023 | ||||||
| Net income | $ | 7,531 | $ | 7,425 | ||||
| Net income margin | 5.8 | % | 6.0 | % | ||||
| Interest expense | 162 | 104 | ||||||
| Income tax expense | 1,982 | 1,388 | ||||||
| Depreciation and amortization | 4,369 | 5,042 | ||||||
| EBITDA | $ | 14,044 | $ | 13,959 | ||||
| Interest income | (583 | ) | (586 | ) | ||||
| Warrant contra revenue | — | 287 | ||||||
| Foreign currency loss / (gain) | 1,457 | (797 | ) | |||||
| Share-based compensation expense | 670 | 848 | ||||||
| Adjusted EBITDA | $ | 15,588 | $ | 13,711 | ||||
| Adjusted EBITDA margin | 12.0 | % | 11.0 | % | ||||
EXHIBIT 3: Free cash flow
We define free cash flow as net cash provided by operating activities less capital expenditures.
| Three Months Ended September 30, | ||||||
| ( | 2024 | 2023 | ||||
| Net cash provided by operating activities | $ | 7,762 | $ | 8,684 | ||
| Less: capital expenditures | 3,630 | 2,052 | ||||
| Free cash flow | $ | 4,132 | $ | 6,632 | ||
EXHIBIT 4: Net cash
We define net cash as total cash and cash equivalents less debt.
| ( | September 30, 2024 | June 30, 2024 | ||||
| Cash and cash equivalents | $ | 62,305 | $ | 62,720 | ||
| Debt | ||||||
| Current | $ | 698 | $ | 660 | ||
| Non-current | 802 | 867 | ||||
| Total debt | $ | 1,500 | $ | 1,527 | ||
| Net cash | $ | 60,805 | $ | 61,193 | ||
FAQ
What was IBEX's revenue growth in Q1 FY2025?
How much did IBEX's HealthTech vertical grow in Q1 FY2025?
What is IBEX's revenue guidance for fiscal year 2025?
How many shares did IBEX repurchase in Q1 FY2025?
